marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 11-09-2024
BioLineRx Ltd. Financial Ratios 2011-2024 | BLRX
Annual Financial Ratios BioLineRx Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | -50.0 | -1.4 | -0.9 | -2.1 | -4.0 | -3.7 | -3.7 | -5.7 | -3.7 | -3.8 | -3.6 |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
- | - | - | -0.1 | -0.2 | -0.2 | -0.3 | -0.3 | -0.3 | - | - | - | - |
EV (Enterprise Value) |
46.4 M | 15 M | 1.35 B | 50.9 M | 36.9 M | 59.3 M | 101 M | 60.4 M | 51.1 M | 62.8 M | 73.9 M | 86.4 M | 53.9 M |
EBITDA per Share |
- | - | -0.04 | -1.36 | -2.88 | -3.54 | -4.21 | -4.4 | -4.72 | -7.32 | -11.7 | -19.3 | -18.2 |
EV/EBITDA |
-53.5 | -1.6 | -0.9 | -3.0 | -3.7 | -3.4 | -3.0 | -3.3 | -3.2 | -2.7 | -2.6 | ||
PEG |
- | 1.32 | 0.07 | 0.05 | 0.1 | 0.16 | 0.55 | -0.4 | -0.1 | -0.1 | 0.32 | 0.0 | |
P/B |
- | - | 19.9 | 1.9 | 0.7 | 1.2 | 1.9 | 1.7 | 1.1 | 1.8 | 5.6 | 5.1 | 2.1 |
P/CF |
- | - | -57.4 | -1.8 | -1.0 | -2.0 | -4.8 | -4.0 | -3.1 | -4.0 | -3.2 | -3.8 | -4.1 |
ROE % |
- | - | - | -136.27 | -76.23 | -55.57 | -46.05 | -45.23 | -30.25 | -32.03 | -151.01 | -136.37 | -58.52 |
ROA % |
- | - | -33.24 | -63.48 | -47.50 | -40.83 | -39.94 | -40.68 | -28.07 | -28.13 | -88.44 | -83.99 | -44.95 |
ROCE % |
- | - | - | -104.07 | -67.58 | -51.75 | -46.53 | -46.81 | -33.63 | -47.65 | -103.99 | -122.10 | -68.24 |
Current Ratio |
1.3 | 3.0 | 6.1 | 1.9 | 2.7 | 3.8 | 7.5 | 9.9 | 15.3 | 12.1 | 6.3 | 3.5 | 4.0 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios BioLineRx Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | - | -0.01 | - | - | - | -0.03 | - | - | - | -0.04 | - | - | - | -0.05 | - | - | - | -0.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | -0.01 | - | - | - | -0.03 | - | - | - | -0.04 | - | - | - | -0.05 | - | - | - | -0.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
- | - | -9.26 | -18.52 | -18.52 | -9.26 | -32.42 | -46.32 | -46.32 | -23.16 | -36.29 | -26.26 | -26.26 | -13.13 | -23.49 | -20.73 | -20.73 | -10.37 | -18.89 | -17.05 | -17.05 | -8.53 | -8.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
- | - | -7.49 | -14.98 | -14.98 | -7.49 | -20.27 | -25.55 | -25.55 | -12.78 | -21.63 | -17.71 | -17.71 | -8.85 | -18.02 | -18.34 | -18.34 | -9.17 | -9.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | -8.00 | -16.00 | -16.00 | -8.00 | -21.49 | -26.98 | -26.98 | -13.49 | -25.62 | -24.26 | -24.26 | -12.13 | -24.35 | -24.44 | -24.44 | -12.22 | -21.26 | -18.09 | -18.09 | -9.04 | -9.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | 6.1 | - | 5.2 | - | 1.9 | - | 2.2 | - | 2.6 | - | 3.1 | - | 3.8 | - | 8.7 | - | 7.5 | - | - | - | 9.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency